vs
Pursuit Attractions & Hospitality, Inc.(PRSU)与RECURSION PHARMACEUTICALS, INC.(RXRX)财务数据对比。点击上方公司名可切换其他公司
Pursuit Attractions & Hospitality, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.6倍($57.1M vs $35.5M),Pursuit Attractions & Hospitality, Inc.净利率更高(-45.9% vs -304.2%,领先258.4%),RECURSION PHARMACEUTICALS, INC.同比增速更快(681.7% vs 24.6%),Pursuit Attractions & Hospitality, Inc.自由现金流更多($-44.6M vs $-47.3M),过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高(60.5% vs -53.2%)
珀西尤特景点 hospitality 公司是一家全球性景点与酒店管理企业,业务布局加拿大、美国、冰岛与哥斯达黎加。公司在加拿大落基山脉的班夫、贾斯珀、沃特顿,阿拉斯加的迪纳利、基奈峡湾国家公园沿线,蒙大拿冰川景区,冰岛以及哥斯达黎加阿雷纳尔地区,自营景点、住宿、餐饮、零售与交通业务。
Recursion Pharmaceuticals是一家临床阶段生物技术企业,依托人工智能技术和高通量生物实验体系,开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法,核心市场覆盖北美,与全球多家生物制药企业合作推进在研管线落地。
PRSU vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $57.1M | $35.5M |
| 净利润 | $-26.2M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -49.5% | -304.8% |
| 净利率 | -45.9% | -304.2% |
| 营收同比 | 24.6% | 681.7% |
| 净利润同比 | -108.4% | 39.6% |
| 每股收益(稀释后) | $-0.89 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
| Q4 25 | $57.1M | $35.5M | ||
| Q3 25 | $241.0M | $5.2M | ||
| Q2 25 | $116.7M | $19.2M | ||
| Q1 25 | — | $14.7M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | $182.3M | $26.1M | ||
| Q2 24 | $101.2M | $14.4M | ||
| Q1 24 | — | $13.8M |
| Q4 25 | $-26.2M | $-108.1M | ||
| Q3 25 | $73.9M | $-162.3M | ||
| Q2 25 | $5.6M | $-171.9M | ||
| Q1 25 | — | $-202.5M | ||
| Q4 24 | — | $-178.9M | ||
| Q3 24 | $48.6M | $-95.8M | ||
| Q2 24 | $29.3M | $-97.5M | ||
| Q1 24 | — | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | 91.8% | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | 90.7% | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | -49.5% | -304.8% | ||
| Q3 25 | 43.9% | -3327.6% | ||
| Q2 25 | 9.1% | -916.8% | ||
| Q1 25 | — | -1297.9% | ||
| Q4 24 | — | -4042.4% | ||
| Q3 24 | 50.8% | -377.1% | ||
| Q2 24 | 52.8% | -697.4% | ||
| Q1 24 | — | -698.4% |
| Q4 25 | -45.9% | -304.2% | ||
| Q3 25 | 30.6% | -3135.3% | ||
| Q2 25 | 4.8% | -894.2% | ||
| Q1 25 | — | -1373.3% | ||
| Q4 24 | — | -3935.5% | ||
| Q3 24 | 26.7% | -367.5% | ||
| Q2 24 | 29.0% | -676.6% | ||
| Q1 24 | — | -662.4% |
| Q4 25 | $-0.89 | $-0.17 | ||
| Q3 25 | $2.60 | $-0.36 | ||
| Q2 25 | $0.20 | $-0.41 | ||
| Q1 25 | — | $-0.50 | ||
| Q4 24 | — | $-0.56 | ||
| Q3 24 | $1.65 | $-0.34 | ||
| Q2 24 | $0.98 | $-0.40 | ||
| Q1 24 | — | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $31.1M | $743.3M |
| 总债务越低越好 | $155.0M | $9.6M |
| 股东权益账面价值 | $581.8M | $1.1B |
| 总资产 | $965.4M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.27× | 0.01× |
8季度趋势,按日历期对齐
| Q4 25 | $31.1M | $743.3M | ||
| Q3 25 | $33.8M | $659.8M | ||
| Q2 25 | $24.7M | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | $64.6M | $427.6M | ||
| Q2 24 | $59.4M | $474.3M | ||
| Q1 24 | — | $296.3M |
| Q4 25 | $155.0M | $9.6M | ||
| Q3 25 | $124.5M | $11.9M | ||
| Q2 25 | $82.4M | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | $381.9M | $20.5M | ||
| Q2 24 | $469.3M | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $581.8M | $1.1B | ||
| Q3 25 | $607.2M | $1.0B | ||
| Q2 25 | $528.4M | $919.1M | ||
| Q1 25 | — | $933.9M | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | $96.8M | $524.6M | ||
| Q2 24 | $41.2M | $584.4M | ||
| Q1 24 | — | $401.2M |
| Q4 25 | $965.4M | $1.5B | ||
| Q3 25 | $996.8M | $1.4B | ||
| Q2 25 | $893.1M | $1.3B | ||
| Q1 25 | — | $1.3B | ||
| Q4 24 | — | $1.4B | ||
| Q3 24 | $1.2B | $726.5M | ||
| Q2 24 | $1.2B | $775.9M | ||
| Q1 24 | — | $557.8M |
| Q4 25 | 0.27× | 0.01× | ||
| Q3 25 | 0.21× | 0.01× | ||
| Q2 25 | 0.16× | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | 3.95× | 0.04× | ||
| Q2 24 | 11.39× | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-13.6M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-44.6M | $-47.3M |
| 自由现金流率自由现金流/营收 | -78.1% | -133.1% |
| 资本支出强度资本支出/营收 | 54.2% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $140.9M | $-378.3M |
8季度趋势,按日历期对齐
| Q4 25 | $-13.6M | $-46.1M | ||
| Q3 25 | $102.6M | $-117.4M | ||
| Q2 25 | $21.6M | $-76.4M | ||
| Q1 25 | — | $-132.0M | ||
| Q4 24 | — | $-115.4M | ||
| Q3 24 | $110.4M | $-59.2M | ||
| Q2 24 | $30.3M | $-82.2M | ||
| Q1 24 | — | $-102.3M |
| Q4 25 | $-44.6M | $-47.3M | ||
| Q3 25 | $86.8M | $-117.6M | ||
| Q2 25 | $3.2M | $-79.6M | ||
| Q1 25 | — | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | $95.4M | $-63.8M | ||
| Q2 24 | $13.1M | $-83.4M | ||
| Q1 24 | — | $-109.0M |
| Q4 25 | -78.1% | -133.1% | ||
| Q3 25 | 36.0% | -2272.5% | ||
| Q2 25 | 2.8% | -413.9% | ||
| Q1 25 | — | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | 52.4% | -244.6% | ||
| Q2 24 | 13.0% | -578.5% | ||
| Q1 24 | — | -789.9% |
| Q4 25 | 54.2% | 3.5% | ||
| Q3 25 | 6.6% | 4.7% | ||
| Q2 25 | 15.7% | 16.4% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | 8.2% | 17.5% | ||
| Q2 24 | 16.9% | 8.2% | ||
| Q1 24 | — | 48.2% |
| Q4 25 | — | — | ||
| Q3 25 | 1.39× | — | ||
| Q2 25 | 3.83× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.27× | — | ||
| Q2 24 | 1.03× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PRSU
| Services Transferred Over Time | $44.7M | 78% |
| Food And Beverage | $9.1M | 16% |
| Retail Operations | $3.3M | 6% |
RXRX
暂无分部数据